Marodyne Medical Taps World-Renowned Professionals for Scientific Advisory Board

Aug. 11, 2010 - PRLog -- LAKELAND, FL. – Marodyne Medical today announced the formation of a Scientific Advisory Board that will work in tandem with executive leadership to guide the company in its mission to develop safe and effective non-drug treatments for acute injury and chronic metabolic diseases.

Clinton Rubin, Ph.D., Chief Scientific Officer of Marodyne, stated: “It is a wonderful vote of confidence for Marodyne to have been able to recruit such an outstanding panel of scientists and clinicians to our Scientific Advisory Board.  We now have a superb resource to help us define our long range scientific plan and research and development targets, as well as to join us in identifying new areas of emphasis for of technologies and intellectual property.  The SAB represents an international power-house of scientific expertise in areas ranging from osteoporosis, diabetes, metabolic disorders, obesity, trauma and reconstruction, rehabilitative medicine and stem cell biology.  This is a very exciting advance for our young company.”

Lance McNeill, CEO of Marodyne, continued: “The main function of this internationally renowned SAB will be to provide the senior members of Marodyne with insight into the scientific basis of the anabolic nature of the Low Intensity Vibration (LIV) signal.  Several members have received funding for their research from the National Institutes of Health, NASA, and the U.S. Army.  It is a very exciting time for our company.”

Scientific Advisory Board Members
Scott Boden, M.D.
John B. Buse, M.D., Ph.D.
Victor Frankel, M.D., Ph.D., KNO
Vicente Gilsanz, M.D., Ph.D.
Douglas Kiel, M.D., MPH
Stefan Judex, Ph.D.
Mary B. Leonard, M.D., MSCE
Takashi Matsushita, M.D., PhD
Jeffrey Pessin, Ph.D.
Clifford J. Rosen, M.D.
Janet Rubin, M.D.

For more information about the Marodyne Scientific Advisory Board members, visit http://www.marodyne.com/company/board.html.


About Marodyne
Marodyne Medical is working to restore mobility, vitality, and independence to the individual patient, in a place of care or at home. Building on 25 years of research and development, and guided by some of the best minds in the medical and scientific field, we are developing safe and effective non-drug treatments for acute injury and chronic metabolic diseases such as osteoporosis, obesity, diabetes, and bone marrow failure through use of our low intensity vibration device, which unlike whole body vibration, utilizes low-level high frequency bio-physical stimuli.    We are committed to investing in scientific research and translating that sound science to you. For more information, visit http://www.marodyne.com.

# # #

Marodyne Medical develops safe and effective non-drug treatments for acute injury and chronic metabolic diseases working with scientific expertise in areas from osteoporosis, diabetes, metabolic disorders, obesity, rehab. med. and stem cell biology.